Glenmark Pharma trades high on the bourses

12 Apr 2017 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 877.00, up by 3.15 points or 0.36% from its previous closing of Rs. 873.85 on the BSE.

The scrip opened at Rs. 877.35 and has touched a high and low of Rs. 881.05 and Rs. 872.25 respectively. So far 8207 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 993.00 on 01-Nov-2016 and a 52 week low of Rs. 729.30 on 24-Jun-2016.

Last one week high and low of the scrip stood at Rs. 881.05 and Rs. 858.00 respectively. The current market cap of the company is Rs. 24652.46 crore.

The promoters holding in the company stood at 46.50%, while institutions and non-institutions held 40.80% and 12.69% respectively.

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor Micronized Capsules, 67 mg, 134 mg, and 200 mg of AbbVie, Inc.

According to IMS Health sales data for the 12 month period ending February 2017, the Tricor Micronized Capsules, 67 mg, 134 mg and 200 mg market achieved annual sales of approximately $97.5 million.

Glenmark’s current portfolio consists of 114 products authorized for distribution in the US marketplace and approximately 64 ANDA’s pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharma Share Price

2018.25 11.35 (0.57%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×